349 related articles for article (PubMed ID: 16886688)
1. Vitamin D--metabolism in the human breast cancer cell line MCF-7.
Diesing D; Cordes T; Fischer D; Diedrich K; Friedrich M
Anticancer Res; 2006; 26(4A):2755-9. PubMed ID: 16886688
[TBL] [Abstract][Full Text] [Related]
2. Analysis of 25-hydroxyvitamin D3-1alpha-hydroxylase in normal and malignant breast tissue.
Friedrich M; Diesing D; Cordes T; Fischer D; Becker S; Chen TC; Flanagan JN; Tangpricha V; Gherson I; Holick MF; Reichrath J
Anticancer Res; 2006; 26(4A):2615-20. PubMed ID: 16886671
[TBL] [Abstract][Full Text] [Related]
3. 25-hydroxy-vitamin d metabolism in human colon cancer cells during tumor progression.
Bareis P; Bises G; Bischof MG; Cross HS; Peterlik M
Biochem Biophys Res Commun; 2001 Jul; 285(4):1012-7. PubMed ID: 11467853
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D, calcidiol and calcitriol regulate vitamin D metabolizing enzymes in cervical and ovarian cancer cells.
Kloss M; Fischer D; Thill M; Friedrich M; Cordes T; Salehin D; Diedrich K; Köster F
Anticancer Res; 2010 Nov; 30(11):4429-34. PubMed ID: 21115889
[TBL] [Abstract][Full Text] [Related]
5. Autocrine metabolism of vitamin D in normal and malignant breast tissue.
Townsend K; Banwell CM; Guy M; Colston KW; Mansi JL; Stewart PM; Campbell MJ; Hewison M
Clin Cancer Res; 2005 May; 11(9):3579-86. PubMed ID: 15867263
[TBL] [Abstract][Full Text] [Related]
6. 25-Hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha-hydroxylated vitamin D analogue.
Segersten U; Holm PK; Björklund P; Hessman O; Nordgren H; Binderup L; Akerström G; Hellman P; Westin G
Breast Cancer Res; 2005; 7(6):R980-6. PubMed ID: 16280049
[TBL] [Abstract][Full Text] [Related]
7. Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3).
Bareis P; Kállay E; Bischof MG; Bises G; Hofer H; Pötzi C; Manhardt T; Bland R; Cross HS
Exp Cell Res; 2002 Jun; 276(2):320-7. PubMed ID: 12027461
[TBL] [Abstract][Full Text] [Related]
8. 25-Hydroxyvitamin D(3) is an agonistic vitamin D receptor ligand.
Lou YR; Molnár F; Peräkylä M; Qiao S; Kalueff AV; St-Arnaud R; Carlberg C; Tuohimaa P
J Steroid Biochem Mol Biol; 2010 Feb; 118(3):162-70. PubMed ID: 19944755
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D metabolism in human prostate cells: implications for prostate cancer chemoprevention by vitamin D.
Flanagan JN; Young MV; Persons KS; Wang L; Mathieu JS; Whitlatch LW; Holick MF; Chen TC
Anticancer Res; 2006; 26(4A):2567-72. PubMed ID: 16886665
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D metabolism in human colon adenocarcinoma-derived Caco-2 cells: expression of 25-hydroxyvitamin D3-1alpha-hydroxylase activity and regulation of side-chain metabolism.
Cross HS; Peterlik M; Reddy GS; Schuster I
J Steroid Biochem Mol Biol; 1997 May; 62(1):21-8. PubMed ID: 9366495
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome P450 enzymes in the bioactivation of vitamin D to its hormonal form (review).
Wikvall K
Int J Mol Med; 2001 Feb; 7(2):201-9. PubMed ID: 11172626
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the vitamin D system in basal cell carcinomas (BCCs).
Mitschele T; Diesel B; Friedrich M; Meineke V; Maas RM; Gärtner BC; Kamradt J; Meese E; Tilgen W; Reichrath J
Lab Invest; 2004 Jun; 84(6):693-702. PubMed ID: 15077124
[TBL] [Abstract][Full Text] [Related]
13. Role of 24-hydroxylase in vitamin D3 growth response of OVCAR-3 ovarian cancer cells.
Miettinen S; Ahonen MH; Lou YR; Manninen T; Tuohimaa P; Syvälä H; Ylikomi T
Int J Cancer; 2004 Jan; 108(3):367-73. PubMed ID: 14648702
[TBL] [Abstract][Full Text] [Related]
14. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D-24-hydroxylase in benign and malignant breast tissue and cell lines.
Fischer D; Becker S; Cordes T; Bücker B; Diedrich K; Friedrich M; Salehin D; Thill M
Anticancer Res; 2009 Sep; 29(9):3641-5. PubMed ID: 19667160
[TBL] [Abstract][Full Text] [Related]
16. Differential biological effects of 1,25-dihydroxyVitamin D3 on melanoma cell lines in vitro.
Seifert M; Rech M; Meineke V; Tilgen W; Reichrath J
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):375-9. PubMed ID: 15225804
[TBL] [Abstract][Full Text] [Related]
17. In vitro comparison of the vitamin D endocrine system in 1,25(OH)2D3-responsive and -resistant melanoma cells.
Reichrath J; Rech M; Moeini M; Meese E; Tilgen W; Seifert M
Cancer Biol Ther; 2007 Jan; 6(1):48-55. PubMed ID: 17172823
[TBL] [Abstract][Full Text] [Related]
18. 25(OH)D3 and 1,25(OH)2D3 serum concentration and breast tissue expression of 1alpha-hydroxylase, 24-hydroxylase and Vitamin D receptor in women with and without breast cancer.
de Lyra EC; da Silva IA; Katayama ML; Brentani MM; Nonogaki S; Góes JC; Folgueira MA
J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):184-92. PubMed ID: 16828283
[TBL] [Abstract][Full Text] [Related]
19. Expression of 25-hydroxyvitamin D3-24-hydroxylase activity in Caco-2 cells. An in vitro model of intestinal vitamin D catabolism.
Tomon M; Tenenhouse HS; Jones G
Endocrinology; 1990 Jun; 126(6):2868-75. PubMed ID: 2351099
[TBL] [Abstract][Full Text] [Related]
20. 25-Hydroxyvitamin D3 1alpha-hydroxylase splice variants in breast cell lines MCF-7 and MCF-10.
Fischer D; Seifert M; Becker S; Ludders D; Cordes T; Reichrath J; Friedrich M
Cancer Genomics Proteomics; 2007; 4(4):295-300. PubMed ID: 17878529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
